ViewRay to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) has announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference from November 23 to December 3, 2020. A fireside chat recording will be available for registered attendees on the conference site, and it will also be posted on the Company's website. On December 1st, ViewRay will hold investor meetings, which must be requested through Piper Sandler. ViewRay specializes in the MRIdian radiation therapy system, focusing on advanced radiation oncology solutions.

News Market Reaction – VRAY

+0.80%

+0.80% News Effect

On the day this news was published, VRAY gained 0.80%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, Nov. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference.

From November 23 to December 3, 2020, a fireside chat recording will be available for registered attendees via the Piper Sandler conference site. A recording will also be posted to the Company's website at https://investors.viewray.com/events-and-presentations/upcoming-events.

ViewRay will be participating in investor meetings on Tuesday, December 1st, which can be requested exclusively via Piper Sandler.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian^® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference-301178411.html

SOURCE ViewRay, Inc.

FAQ

What is the significance of ViewRay's participation in the Piper Sandler conference?

ViewRay's participation highlights its commitment to engaging with investors and showcasing its innovative MRIdian radiation therapy system.

When will the fireside chat recording be available for ViewRay?

The fireside chat recording will be available from November 23 to December 3, 2020.

How can I access ViewRay's investor meeting on December 1st?

Investor meetings on December 1st must be requested exclusively through Piper Sandler.

What products does ViewRay, Inc. focus on?

ViewRay, Inc. specializes in the MRIdian radiation therapy system, designed for advanced radiation oncology.

Where can I find more information about ViewRay's participation in the conference?

More information can be found on ViewRay's website under the events and presentations section.